Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Rich Yield Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Biopharma
  • Drug Discovery
  • Pharmaceutical
  • Medical Device
Summary

The typical case for the fund is to invest in rounds with 4 participants. Despite the Rich Yield Capital, startups are often financed by Value Measured Investment Limited, Sangel Biomedical Venture Capital, Qianhai Shenghui Investment. The meaningful sponsors for the fund in investment in the same round are Rolling Boulder Investment, Legend Sky Investment, CR-CP Life Sciences Fund.

The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. The fund is generally included in less than 2 deals every year.

Among the most popular portfolio startups of the fund, we may highlight Sirnaomics. We can highlight the next thriving fund investment areas, such as Biopharma, Medical Device. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Rich Yield Capital:
Typical Co-investors
Rich Yield Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Rich Yield Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AxVentures-Pymar Fund Argentina, Buenos Aires, Distrito Federal
Chronos Fund -
Dangtang Canyin Guanli China, Hangzhou, Zhejiang
Delta Ventures Glil Yam, Israel, Tel Aviv
East River Capital New York, New York, United States
Erie County Industrial Development Agency Buffalo, New York, United States
Favonius Ventures -
FOREIS dotation fund -
Jade Capital Beijing, Beijing, China
JiranSecurity Seoul-t'ukpyolsi, South Korea, Yeoksamdong
JordInvest Amman, Amman, Jordan
JSCapital Israel, Tel Aviv, Tel Aviv District
Mandarin Capital Partners Italy, Lombardia, Milano
Neon Enterprise Software Austin, Texas, United States
NUMA Barcelona Barcelona, Catalonia, Spain
R/GA Accelerator New York, New York, United States
Stacks New York, New York, United States
Tokyo Tanshi Japan, Tokyo
Tomales Bay Capital California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sirnaomics

Biopharma
Biotechnology
Drug Discovery
Medical Device
Pharmaceutical
$22M29 Apr 2019 Maryland, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Rich Yield Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 22M
Peak activity year 2019
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sirnaomics

Biopharma
Biotechnology
Drug Discovery
Medical Device
Pharmaceutical
$22M29 Apr 2019 Maryland, United States
Crunchbase icon

Content report

The following text will be sent to our editors: